CCND1 and breast cancer: In ER+ breast cancer, miR-129 inhibits estrogen receptor 1 (ESR1)-mediated NOTCH signaling in CSC-like cells by suppressing cyclin D1/DICER1 mediated let-7 maturation, leading to increased NUMB expression to repress NOTCH signaling activity [91].